CN110623992B - Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) - Google Patents
Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) Download PDFInfo
- Publication number
- CN110623992B CN110623992B CN201810658499.3A CN201810658499A CN110623992B CN 110623992 B CN110623992 B CN 110623992B CN 201810658499 A CN201810658499 A CN 201810658499A CN 110623992 B CN110623992 B CN 110623992B
- Authority
- CN
- China
- Prior art keywords
- folium artemisiae
- artemisiae argyi
- quantum dots
- charcoal
- carbon quantum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/65—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing carbon
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Optics & Photonics (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Mycology (AREA)
- Manufacturing & Machinery (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
Abstract
The invention relates to a method for extracting, separating and purifying quantum dots (nano particles/nano particles) from folium artemisiae argyi charcoal, which comprises the following steps: the folium artemisiae argyi charcoal is extracted or extracted by a solvent, and dialyzed by a dialysis bag with the molecular weight of more than 1000Da or ultrafiltered to obtain folium artemisiae argyi charcoal quantum dots, wherein the quantum dots are blue fluorescence under an ultraviolet lamp of 365nm, have the particle size of less than 100nm measured by a transmission electron microscope and mainly comprise C, H, O, N and other elements; the invention also relates to the application of the quantum dot in the field of medicine, which is used for resisting inflammation, improving the tolerance degree of the body to cold and the like after administration by injection, oral administration or external application and the like.
Description
Technical Field
The invention belongs to the technical field of medicines, and particularly relates to preparation of folium artemisiae argyi carbon quantum dots and application of the folium artemisiae argyi carbon quantum dots in the field of medicines.
Background
Since ancient times, methods of treating diseases with charcoal are widely described in medical books of the past dynasties. The pharmacopoeia of the people's republic of China records that it has the functions of warming meridians, stopping bleeding, dispelling cold and relieving pain. The preparation method of the folium artemisiae argyi charcoal mainly comprises the following four methods:
1. direct firing method: cleaning folium Artemisiae Argyi, drying, burning on alcohol burner until dense smoke is formed, burning completely to form cellular loose carbon block, and filtering with Gong or gauze.
2. Pan-frying: cleaning folium Artemisiae Argyi, air drying, parching with slow fire for half an hour until concentrated into mass and dense smoke becomes gradually light into charcoal.
3. A closed-burning method: and (4) collecting folium artemisiae argyi, rinsing with clear water and drying. A small pot or a pot with holes is covered on the pot or the porcelain container. Sealing the joint of the two pots with mud, pressing a weight on the pot, and calcining with slow and strong fire. Generally, the rice or white paper covered on the pot is burnt to be yellow.
4. Baking: placing the folium artemisiae argyi in a drying oven at 275-280 ℃, drying until the thermometer smokes and takes out the folium artemisiae argyi when the folium artemisiae argyi has slight fishy smell.
The folium artemisiae argyi charcoal mainly comprises inorganic elements such as carbon, nitrogen and calcium.
Disclosure of Invention
The quantum dots (nano particles/nano particles) are extracted and separated from the folium artemisiae argyi carbon for the first time, and the folium artemisiae argyi carbon quantum dots are found to have strong biological effects of improving the tolerance degree of animals to cold, resisting inflammation and the like for the first time. The technical scheme is as follows: the invention provides a method for extracting and separating carbon quantum dots from folium artemisiae argyi carbon. The invention also provides the biological activity of the folium artemisiae argyi carbon quantum dots and the application of the folium artemisiae argyi carbon quantum dots in the field of medicines.
The preparation method specifically comprises the following steps: baking to prepare folium Artemisiae Argyi charcoal, extracting quantum dots from folium Artemisiae Argyi charcoal with solvent, and further separating and purifying by dialysis, ultrafiltration, chromatography, etc. to obtain high purity carbon quantum dots.
Drawings
FIG. 1 is a high performance liquid chromatogram of folium Artemisiae Argyi FIG. 1(a) and folium Artemisiae Argyi carbon quantum dot diagram 1(b)
FIG. 2 shows a morphology chart of folium Artemisiae Argyi carbon quantum dot under a transmission electron microscope 2(a), a high resolution transmission electron microscope 2(b), an X-ray diffraction chart 2(c), an ultraviolet spectrum chart 2(d), a fluorescence spectrum chart 2(e), and an infrared spectrum chart 2(f)
FIG. 3 shows the X-ray photoelectron spectrum 3(a), the carbon spectrum 3(b), the oxygen spectrum 3(c), and the nitrogen spectrum 3(d) of the quantum dot of folium Artemisiae Argyi carbon
FIG. 4 shows the effect of different doses of folium Artemisiae Argyi charcoal quantum dots on the concentration of interleukin 1-beta in mouse serum 4(a), the effect on the concentration of tumor necrosis factor in mouse serum 4(b), and the anti-mouse-freezing effect 4 (c).
FIG. 5 is a photograph and a slice of folium artemisiae argyi carbon quantum dots with different dosages for preventing and treating frostbite of mouse ear margins
Detailed Description
Example 1: preparation of folium artemisiae argyi carbon quantum dots
Weighing clean folium Artemisiae Argyi, placing in a crucible, covering, placing in a muffle furnace, heating to 285 deg.C, maintaining constant temperature for 1h, naturally cooling to room temperature, opening the muffle furnace, and taking out to obtain folium Artemisiae Argyi charcoal.
Extracting folium Artemisiae Argyi charcoal with pure water for 3 times, mixing the water solutions, concentrating, and dialyzing with 1KD dialysis bag, wherein the part in the dialysis bag is high-purity folium Artemisiae Argyi charcoal carbon quantum dot solution.
Example 2: preparation of folium artemisiae argyi carbon quantum dots
Weighing clean folium Artemisiae Argyi, placing in a crucible, covering, placing in a muffle furnace, heating to 350 deg.C, maintaining constant temperature for 1h, naturally cooling to room temperature, opening the muffle furnace, and taking out to obtain folium Artemisiae Argyi charcoal.
Extracting folium Artemisiae Argyi charcoal with pure water for 3 times, mixing the water solutions, concentrating, and ultrafiltering with 10KD ultrafilter tube to obtain high purity folium Artemisiae Argyi charcoal carbon quantum dot solution.
Example 3 folium Artemisiae Argyi carbon quantum dots improve the tolerance of the body to cold
Anti-freezing experiment of mice:
1. the night before the experiment was fasted for 12 hours and fed normally. On the day of the experiment, the mice are weighed and divided into physiological saline groups; a group of positive drugs; a high dose group; a medium dose group; low dose group.
2. The labeled mice are separately packaged for later use. The drugs were administered two hours prior to the experiment, respectively, to allow for adequate absorption of the drug. After the holding power of each mouse is measured, the mouse is placed in ice water with the temperature of 0 ℃, is fished out after swimming for 5 minutes, and the holding power is measured again in time, and the relative change value of the holding power is calculated, so that the reaction stiffness degree is obtained.
3. The results are shown in fig. 4, and the three doses, high, medium and low, all have significant anti-freeze effects compared to the normal group (blank group shows that there is still a certain relative change in the mouse's grip without ice-water bath.
The anti-freezing effect of the mouse is as follows:
1. the night before the experiment was fasted for 12 hours and fed normally. The mice were weighed and labeled the day of the experiment.
2. Two hours before the experiment, the mice are subjected to modeling for one week in the ice-water bath method, the mice are killed 12 hours after the last modeling, the serum of the mice is taken to measure inflammatory factors, and the frozen ear margins of the mice are taken to be subjected to HE staining and slicing.
3. The results are shown in fig. 4 and fig. 5, and the high, medium and low doses all have anti-freezing effect compared with the normal group, so that the injury of cold stimulation to mouse tissues can be effectively reduced, and the level of inflammatory factors can be reduced.
Claims (2)
1. The application of the folium artemisiae argyi carbon quantum dots in preparing the medicine for treating frostbite comprises the following steps: placing folium Artemisiae Argyi in a crucible, covering, placing in a muffle furnace, heating to 285 deg.C or 350 deg.C, maintaining constant temperature for 1 hr, naturally cooling to room temperature, and taking out to obtain folium Artemisiae Argyi charcoal; extracting folium Artemisiae Argyi charcoal with pure water, dialyzing with dialysis bag with molecular weight of 1-10 KDa, collecting the fraction retained in the dialysis bag, or ultrafiltering with ultrafiltration tube of 10KD, and collecting the filtrate fraction to obtain folium Artemisiae Argyi charcoal quantum dot; the characteristics of the obtained carbon quantum dots: blue fluorescence under an ultraviolet lamp of 365nm, the particle size measured by a transmission electron microscope is 1-20nm, and the elements of the quantum dots mainly comprise C, O and N elements.
2. The use of claim 1, in the form of injection, oral liquid, hard capsule, soft capsule, tablet, suppository, watered pill, honeyed pill, concentrated pill, paste, powder, emulsion, paste, or liniment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810658499.3A CN110623992B (en) | 2018-06-22 | 2018-06-22 | Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810658499.3A CN110623992B (en) | 2018-06-22 | 2018-06-22 | Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110623992A CN110623992A (en) | 2019-12-31 |
CN110623992B true CN110623992B (en) | 2022-03-18 |
Family
ID=68967108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810658499.3A Active CN110623992B (en) | 2018-06-22 | 2018-06-22 | Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110623992B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110623996A (en) * | 2018-06-22 | 2019-12-31 | 北京中医药大学 | Preparation and application of schizonepeta spike carbon quantum dots (nanoparticles/nanoparticles) |
CN111248190B (en) * | 2020-03-19 | 2021-04-27 | 中国科学院化学研究所 | Application of carbon dots as antifreeze material |
CN111840100A (en) * | 2020-08-06 | 2020-10-30 | 郑州大学 | Antibacterial washing and protecting liquid based on antibacterial carbon nanodots, and preparation method and application thereof |
CN114569648A (en) * | 2020-12-01 | 2022-06-03 | 北京中医药大学 | Preparation and application of carbon nano particles of sophora flavescens |
-
2018
- 2018-06-22 CN CN201810658499.3A patent/CN110623992B/en active Active
Non-Patent Citations (1)
Title |
---|
Novel carbon dots derived from Schizonepetae Herba Carbonisata and investigation of their haemostatic efficacy;Meiling Zhang et al;《Artificial Cells,Nanomedicine, and Biotechnology》;20170919;第46卷(第8期);第1562-1571页,尤其是第1563页右栏第2-3段,第1565页左栏最后一段,第1565页右栏,第1566页左栏第1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN110623992A (en) | 2019-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110623992B (en) | Preparation and application of folium artemisiae argyi carbon quantum dots (nanoparticles/nanoparticles) | |
CN117959374A (en) | Preparation method and application of medicinal and edible traditional Chinese medicine health care moxibustion fumigating and drinking composition | |
CN103142987B (en) | Medicament for treating mumps | |
CN109331043A (en) | A kind of pharmaceutical composition and preparation method thereof for treating ulcer malignant boil furuncle | |
CN104304629A (en) | Traditional Chinese medicine fragrant chewing gum | |
CN110623990B (en) | Preparation and application of Cirsium setosum carbon quantum dots (nanoparticles/nanoparticles) | |
CN105381069A (en) | Traditional Chinese medicine oral liquid for treating hypertension | |
CN106924371A (en) | A kind of lepidium seed date is tonified the kidney to improve inspiration and controls asthma oral liquid | |
CN104706998A (en) | Traditional Chinese medicine spray for treating allergic rhinitis in clinical care and preparation method thereof | |
WO2007059649A1 (en) | Chinese pharmaceutical compositions for treating upper respiratory tract infection and processes for preparation thereof | |
CN104473268A (en) | Honeysuckle-containing beverage and preparation method thereof | |
CN117462620B (en) | Traditional Chinese medicine formula for treating lung cancer and preparation method and application thereof | |
CN107648494A (en) | One kind treats gingivitis and canker sore Chinese medical collutory and preparation method thereof | |
CN116173170B (en) | A pharmaceutical composition for treating respiratory diseases, and its preparation method | |
CN106266504A (en) | A kind of Chinese medicine of nourishing the lung to arrest cough | |
CN106266737A (en) | Congenital whole body hirsutism and treatment Chinese medicine thereof | |
CN106215022A (en) | A kind of containing Herba Androsaces Umbellatae (Herba Androsaces Coccineae) sore-throat relieving Chinese medicine and preparation method | |
WO2006029550A1 (en) | Hemostatic mistura of ipomoea balatas leaves, methods of preparation and use thereof | |
CN107661374A (en) | A kind of special efficacy cold drug and preparation method thereof | |
CN104510784A (en) | Insomnia treatment traditional Chinese medicine composition | |
CN105030936A (en) | Chinese medicine for treating keratoconjunctivitis | |
CN105168821A (en) | Cough-relieving traditional Chinese medicine composition and preparation method thereof | |
CN1245204C (en) | Medicine for curing acute pharyngitis and its preparing method | |
CN104906379A (en) | Traditional Chinese medicine ointment for treating bullous impetigo and preparation method of ointment | |
CN105169123B (en) | A kind of traditional Chinese medicine powder and preparation method thereof for treating children's extreme noxious heat varicella |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |